BACKGROUND & AIMS: The Keap1-Nrf2 signaling pathway regulates host cell defense responses against oxidative stress and maintains the cellular redox balance. METHODS: We investigated the function/molecular mechanisms by which Keap1-Nrf2 complex may influence liver ischemia/reperfusion injury (IRI) in a mouse model of hepatic cold storage (20h at 4°C) followed by orthotopic liver transplantation (OLT). RESULTS: The Keap1 hepatocyte-specific knockout (HKO) in the donor liver ameliorated post-transplant IRI, evidenced by improved hepatocellular function and OLT outcomes (Keap1 HKO→Keap1 HKO; 100% survival), as compared with controls (WT→WT; 50% survival; p<0.01). By contrast, donor liver Nrf2 deficiency exacerbated IRI in transplant recipients (Nrf2 KO→Nrf2 KO; 40% survival). Ablation of Keap1 signaling reduced macrophage/neutrophil trafficking, pro-inflammatory cytokine programs, and hepatocellular necrosis/apoptosis, while simultaneously promoting anti-apoptotic functions in OLTs. At the molecular level, Keap1 HKO increased Nrf2 levels, stimulated Akt phosphorylation, and enhanced expression of anti-oxidant Trx1, HIF-1α, and HO-1. Pretreatment of liver donors with PI3K inhibitor (LY294002) disrupted Akt/HIF-1A signaling and recreated hepatocellular damage in otherwise IR-resistant Keap1 HKO transplants. In parallel in vitro studies, hydrogen peroxide-stressed Keap1-deficient hepatocytes were characterized by enhanced expression of Nrf2, Trx1, and Akt phosphorylation, in association with decreased release of lactate dehydrogenase (LDH) in cell culture supernatants. CONCLUSIONS: Keap1-Nrf2 complex prevents oxidative injury in IR-stressed OLTs through Keap1 signaling, which negatively regulates Nrf2 pathway. Activation of Nrf2 induces Trx1 and promotes PI3K/Akt, crucial for HIF-1α activity. HIF-1α-mediated overexpression of HO-1/Cyclin D1 facilitates cytoprotection by limiting hepatic inflammatory responses, and hepatocellular necrosis/apoptosis in a PI3K-dependent manner.
BACKGROUND & AIMS: The Keap1-Nrf2 signaling pathway regulates host cell defense responses against oxidative stress and maintains the cellular redox balance. METHODS: We investigated the function/molecular mechanisms by which Keap1-Nrf2 complex may influence liver ischemia/reperfusion injury (IRI) in a mouse model of hepatic cold storage (20h at 4°C) followed by orthotopic liver transplantation (OLT). RESULTS: The Keap1 hepatocyte-specific knockout (HKO) in the donor liver ameliorated post-transplant IRI, evidenced by improved hepatocellular function and OLT outcomes (Keap1 HKO→Keap1 HKO; 100% survival), as compared with controls (WT→WT; 50% survival; p<0.01). By contrast, donorliver Nrf2 deficiency exacerbated IRI in transplant recipients (Nrf2 KO→Nrf2 KO; 40% survival). Ablation of Keap1 signaling reduced macrophage/neutrophil trafficking, pro-inflammatory cytokine programs, and hepatocellular necrosis/apoptosis, while simultaneously promoting anti-apoptotic functions in OLTs. At the molecular level, Keap1 HKO increased Nrf2 levels, stimulated Akt phosphorylation, and enhanced expression of anti-oxidant Trx1, HIF-1α, and HO-1. Pretreatment of liver donors with PI3K inhibitor (LY294002) disrupted Akt/HIF-1A signaling and recreated hepatocellular damage in otherwise IR-resistant Keap1 HKO transplants. In parallel in vitro studies, hydrogen peroxide-stressed Keap1-deficient hepatocytes were characterized by enhanced expression of Nrf2, Trx1, and Akt phosphorylation, in association with decreased release of lactate dehydrogenase (LDH) in cell culture supernatants. CONCLUSIONS:Keap1-Nrf2 complex prevents oxidative injury in IR-stressed OLTs through Keap1 signaling, which negatively regulates Nrf2 pathway. Activation of Nrf2 induces Trx1 and promotes PI3K/Akt, crucial for HIF-1α activity. HIF-1α-mediated overexpression of HO-1/Cyclin D1 facilitates cytoprotection by limiting hepatic inflammatory responses, and hepatocellular necrosis/apoptosis in a PI3K-dependent manner.
Authors: Sarah J Welsh; Ryan R Williams; Anne Birmingham; David J Newman; D Lynn Kirkpatrick; Garth Powis Journal: Mol Cancer Ther Date: 2003-03 Impact factor: 6.261
Authors: Tun Nyunt; Monica Britton; Kwanjeera Wanichthanarak; Madhu Budamagunta; John C Voss; Dennis W Wilson; John C Rutledge; Hnin H Aung Journal: Free Radic Biol Med Date: 2019-07-26 Impact factor: 7.376
Authors: Manash K Paul; Bharti Bisht; Daphne O Darmawan; Richard Chiou; Vi L Ha; William D Wallace; Andrew T Chon; Ahmed E Hegab; Tristan Grogan; David A Elashoff; Jackelyn A Alva-Ornelas; Brigitte N Gomperts Journal: Cell Stem Cell Date: 2014-06-19 Impact factor: 24.633
Authors: C Zhang; Y Zhang; Y Liu; Y Liu; S Kageyama; X-D Shen; F Gao; S Zheng; R W Busuttil; G D Shaw; H Ji; J W Kupiec-Weglinski Journal: Am J Transplant Date: 2017-02-06 Impact factor: 8.086
Authors: Iok In Christine Chio; Seyed Mehdi Jafarnejad; Mariano Ponz-Sarvise; Youngkyu Park; Keith Rivera; Wilhelm Palm; John Wilson; Vineet Sangar; Yuan Hao; Daniel Öhlund; Kevin Wright; Dea Filippini; Eun Jung Lee; Brandon Da Silva; Christina Schoepfer; John Erby Wilkinson; Jonathan M Buscaglia; Gina M DeNicola; Herve Tiriac; Molly Hammell; Howard C Crawford; Edward E Schmidt; Craig B Thompson; Darryl J Pappin; Nahum Sonenberg; David A Tuveson Journal: Cell Date: 2016-07-28 Impact factor: 41.582
Authors: Shi Yue; Jianjun Zhu; Ming Zhang; Changyong Li; Xingliang Zhou; Min Zhou; Michael Ke; Ronald W Busuttil; Qi-Long Ying; Jerzy W Kupiec-Weglinski; Qiang Xia; Bibo Ke Journal: Hepatology Date: 2016-08-29 Impact factor: 17.425
Authors: Yuan Liu; Tianfei Lu; Cheng Zhang; Jin Xu; Zhengze Xue; Ronald W Busuttil; Ning Xu; Qiang Xia; Jerzy W Kupiec-Weglinski; Haofeng Ji Journal: J Hepatol Date: 2019-06-13 Impact factor: 25.083